Professional Documents
Culture Documents
University of Manchester, Manchester, UK; University of North CarolinaChapel Hill, Chapel Hill, North Carolina; University of Medicine and
Pharmacy Iuliu Hatieganu, Cluj, Romania; #Universitatsklinikum Chariter, Berlin, Germany; University of California Los Angeles and VA
GLAHS, Los Angeles, California
unctional abdominal pain syndrome (FAPS) represents a chronic pain disorder localized to the abdomen with features that differentiate it from other painful
functional gastrointestinal disorders. Like other functional gastrointestinal disorders, symptoms are not explainable by a structural or metabolic disorder by using
currently available diagnostic methods. FAPS appears
highly related to alterations in endogenous pain modulation systems, including dysfunction of descending pain
modulation and cortical pain modulation circuits. There
is only 1 recognized diagnosis in this category of functional gastrointestinal disorders (Table 1).
April 2006
1493
social assessment, observation of symptom reporting behaviors (Table 2), and a detailed physical examination.
By answering a few questions, the physician effectively
can appraise the clinical features of FAPS, identify the
key psychosocial contributions to the disorder, and increase confidence in the diagnosis (Table 3).11
Typically, FAPS patients describe abdominal pain in
emotional terms,12 as constant and not influenced by
eating or defecation, as involving a large anatomic area
rather than a precise location, as one of several other
painful symptoms, and as a continuum of painful experiences beginning in childhood or recurring over time.
For patients meeting diagnostic criteria for FAPS who
exhibit a longstanding history of pain behaviors and
certain psychosocial correlates, the clinical evaluation
typically fails to disclose any other specific medical etiology to explain the illness.11 In the absence of alarm
features common to the functional gastrointestinal disorders, conservative efforts should be taken to exclude
other medical conditions in a cost-effective manner. Further detail regarding the clinical evaluation is beyond the
Table 3. Questions for Appraising Clinical Features of FAPS
While Identifying Key Psychosocial Contributors
1.
2.
3.
4.
5.
6.
7.
8.
1494
CLOUSE ET AL
April 2006
1495
treating disability from refractory chronic pain.60 Although the various psychological treatments described
earlier have been shown to improve mood, coping, quality of life, and health care costs, they have less demonstrable impact on specific visceral or somatic symptoms,
suggesting that their best use may be in combination
with symptomatic treatment.44,61 Psychological treatment may be most accepted if presented as a parallel
intervention with ongoing medical care, a means for
managing pain, and an attempt to reduce psychological
distress from the symptoms.
Complementary therapies. Complementary and
alternative therapies, such as spinal manipulation,62,63
massage,64 and acupuncture65 commonly are used by
patients with chronic pain disorders, including FAPS,
although data supporting their use are limited. Few
reports have described the use of transcutaneous electrical
nerve stimulation in patients with FAPS, and uncontrolled results are indeterminant.66 Although uncontrolled studies suggest a significant diagnostic and therapeutic benefit of laparoscopy with intended adhesiolysis
in patients with chronic abdominal pain tentatively attributed to adhesions from prior surgical procedures,67 69
the outcome may be placebo related and unsuspected
diagnoses are rare.70 A blinded, randomized trial of 100
patients undergoing either laparoscopic adhesiolysis or
diagnostic laparoscopy alone found no advantage to adhesiolysis.71 This study also reported a significant improvement in chronic abdominal pain over 6 months
whether laparoscopy alone or laparoscopic adhesiolysis
were performed, suggesting spontaneous improvement
in these patients over time.
1496
CLOUSE ET AL
References
1. Thompson WG, Longstreth G, Drossman DA, Heaton K, Irvine EJ,
Muller-Lissner S. Functional bowel disorders and D. functional
abdominal pain. In: Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE, eds. Rome II: The functional gastrointestinal disorders. Diagnosis, pathophysiology and treatment: A
multinational consensus. Mclean, VA: Degnon Associates, 2000:
351 432.
2. American Psychiatric Association. Diagnostic and statistical manual of mental disordersDSM-IV. Washington, DC: American Psychiatric Association, 1994.
3. Koloski NA, Talley NJ, Boyce PM. Epidemiology and health care
seeking in the functional GI disorders: a population-based study.
Am J Gastroenterol 2002;97:2290 2299.
4. Kwan AC, Bao TN, Chakkaphak S, Chang FY, Ke MY, Law NM,
Leelakusolvong S, Luo JY, Manan C, Park HJ, Piyaniran W,
Qureshi A, Long T, Xu GM, Xu L, Yuen H. Validation of Rome II
criteria for functional gastrointestinal disorders by factor analysis
of symptoms in Asian patient sample. J Gastroenterol Hepatol
2003;18:796 802.
5. Thompson WG, Heaton KW, Smyth GT, Smyth C. Irritable bowel
syndrome in general practice: prevalence, characteristics, and
referral. Gut 2000;46:78 82.
6. Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson
WG, Whitehead WE, Janssens J, Funch-Jensen P, Corazziari E.
U.S. householder survey of functional gastrointestinal disorders.
Prevalence, sociodemography, and health impact. Dig Dis Sci
1993;38:1569 1580.
7. Bharucha AE, Camilleri M. Functional abdominal pain in the elderly. Gastroenterol Clin North Am 2001;30:517529.
8. Maxton DG, Whorwell PJ. Use of medical resource and attitudes
to health care of patients with chronic abdominal pain. Br J Med
Econ 1992;2:7579.
9. Wong HY, Mayer EA. Gastrointestinal pain. In: McMahon S, Koltzenburg M, eds. Wall and Melzack textbook of pain. 5th ed. New
York: Elsevier, 2005.
10. Guthrie EA, Creed FH, Whorwell PJ, Tomenson B. Outpatients
with irritable bowel syndrome: a comparison of first time and
chronic attenders. Gut 1992;33:361311.
11. Drossman DA. Functional abdominal pain syndrome. Clin Gastroenterol Hepatol 2004;2:353365.
12. Drossman DA. Patients with psychogenic abdominal pain: six
years observation in the medical setting. Am J Psychiatry 1982;
139:1549 1557.
13. Devor M. Neuropathic pain: what do we do with all these theories? Acta Anaesthesiol Scand 2001;45:11211127.
14. Ohayon MM, Schatzberg AF. Using chronic pain to predict depressive morbidity in the general population. Arch Gen Psychiatry
2003;60:39 47.
15. Edwards RR, Ness TJ, Weigent DA, Fillingim RB. Individual differences in diffuse noxious inhibitory controls (DNIC): association
with clinical variables. Pain 2003;106:427 437.
16. Wilder-Smith CH, Schindler D, Lovblad K, Redmond SM, Nirkko A.
Brain functional magnetic resonance imaging of rectal pain and
activation of endogenous inhibitory mechanisms in irritable
bowel syndrome patient subgroups and healthy controls. Gut
2004;53:15951601.
17. Petrovic P, Ingvar M. Imaging cognitive modulation of pain processing. Pain 2002;95:15.
18. Lieberman MD, Jarcho JM, Berman S, Naliboff BD, Suyenobu BY,
Mandelkern M, Mayer EA. The neural correlates of placebo effects: a disruption account. Neuroimage 2004;22:447 455.
19. Ringel Y, Drossman DA, Leserman J, Lin W, Liu H, Vogt B,
Whitehead WE. Association of anterior cingulate cortex (ACG)
activation with psychosocial distress and pain reports. Gastroenterology 2003;124:A97.
20. Mayer EA, Derbyshire S, Naliboff BD. Cerebral activation in irritable bowel syndrome. Gastroenterology 2000;119:1418 1420.
21. Mayer EA, Collins SM. Evolving pathophysiologic models of functional gastrointestinal disorders. Gastroenterology 2002;122:
20322048.
22. Bixo M, Sundstrom-Poromaa I, Bjorn I, Astrom M. Patients with
psychiatric disorders in gynecologic practice. Am J Obstet Gynecol 2001;185:396 402.
23. McCracken LM, Zayfert C, Gross RT. The Pain Anxiety Symptoms
Scale: Development and validation of a scale to measure fear of
pain. Pain 1992;50:6773.
24. Hazlett-Stevens H, Craske MG, Mayer EA, Chang L, Naliboff BD.
Prevalence of irritable bowel syndrome among university students: the roles of worry, neuroticism, anxiety sensitivity and
visceral anxiety. J Psychosom Res 2003;55:501505.
25. El Rufaie OE, Al Sabosy MA, Bener A, Abuzeid MS. Somatized
mental disorder among primary care Arab patients: I. Prevalence
and clinical and sociodemographic characteristics. J Psychosom
Res 1999;46:549 555.
26. Petrak F, Hardt J, Kappis B, Nickel R, Tiber EU. Determinants of
health-related quality of life in patients with persistent somatoform pain disorder. Eur J Pain 2003;7:463 471.
27. Sarason IG, Sarason BR, Potter EH III, Antoni MH. Life events,
social support, and illness. Psychosom Med 1985;47:156 163.
28. Jamison RN, Virts KL. The influence of family support on chronic
pain. Behav Res Ther 1990;28:283287.
29. Scarinci IC, McDonald-Haile J, Bradley LA, Richter JE. Altered pain
perception and psychosocial features among women with gastrointestinal disorders and history of abuse: a preliminary model.
Am J Med 1994;97:108 118.
30. Drossman DA, Whitehead WE, Toner BB, Diamant N, Hu YJ,
Bangdiwala SI, Jia H. What determines severity among patients
with painful functional bowel disorders? Am J Gastroenterol
2000;95:974 980.
31. Drossman DA, Leserman J, Li Z, Keefe F, Hu YJ, Toomey TC.
Effects of coping on health outcome among women with gastrointestinal disorders. Psychosom Med 2000;62:309 317.
32. Hislop IG. Childhood deprivation: an antecedent of the irritable
bowel syndrome. Med J Aust 1979;1:372374.
33. Drossman DA, Talley NJ, Leserman J, Olden KW, Barreiro MA.
Sexual and physical abuse and gastrointestinal illness. Review
and recommendations. Ann Intern Med 1995;123:782794.
34. Wurtele SK, Kaplan GM, Keairnes M. Childhood sexual abuse
among chronic pain patients. Clin J Pain 1990;6:110 113.
35. Drossman DA, Li Z, Leserman J, Toomey TC, Hu YJ. Health status
by gastrointestinal diagnosis and abuse history. Gastroenterology 1996;110:999 1007.
36. Mayer EA, Gebhart GF. Basic and clinical aspects of visceral
hyperalgesia. Gastroenterology 1994;107:271293.
April 2006
1497